Showing results (21-30 of 976) with videos related to

Sort By:
Pageof 98
NPJ Breast Cancer|March 26, 2021
De-escalation of radiation therapy in patients with stage I, node-negative, HER2-positive breast cancerJose G Bazan, Sachin R Jhawar, Daniel Stover, et al.
NPJ Breast Cancer|March 26, 2021
Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence riskMark Jesus M Magbanua, Wen Li, Denise M Wolf, et al.
NPJ Breast Cancer|August 11, 2017
Risk stratification with Breast Cancer Index for late distant recurrence in patients with clinically low-risk (T1N0) estrogen receptor-positive breast cancerBrock Schroeder, Yi Zhang, Olle Stål, et al.
NPJ Breast Cancer|July 20, 2017
A multifactorial 'Consensus Signature' by in silico analysis to predict response to neoadjuvant anthracycline-based chemotherapy in triple-negative breast cancerNatalie Turner, Mattia Forcato, Simona Nuzzo, et al.
NPJ Breast Cancer|July 20, 2017
Activin-A signaling promotes epithelial-mesenchymal transition, invasion, and metastatic growth of breast cancerMohsin Bashir, Surekha Damineni, Geetashree Mukherjee, et al.
NPJ Breast Cancer|July 20, 2017
Preventing breast cancer now by acting on what we already knowGraham A Colditz, Kari Bohlke
NPJ Breast Cancer|July 20, 2017
Disparities in breast cancer care and research: report from a Breast Cancer Research Foundation sponsored workshop, 9-10 October 2014Beverly Canin, Karen M Freund, Patricia A Ganz, et al.
NPJ Breast Cancer|July 20, 2017
Decreased gastrointestinal toxicity associated with a novel capecitabine schedule (7 days on and 7 days off): a systematic reviewKaren A Cadoo, Devika Gajria, Emily Suh, et al.
NPJ Breast Cancer|July 20, 2017
The molecular landscape of high-risk early breast cancer: comprehensive biomarker analysis of a phase III adjuvant populationTimothy R Wilson, Jianjun Yu, Xuyang Lu, et al.
NPJ Breast Cancer|July 20, 2017
Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630Ronald K Potkul, Joseph M Unger, Robert B Livingston, et al.
Pageof 98